The Challenge
Meeting an Urgent Medical Need
Current bone repair solutions often fail to provide the necessary structural integrity and biological cues required for successful regeneration. The DENOVOSS consortium addresses this critical gap by developing OssiGel, a cell-free biomaterial derived from engineered human cartilage. Our goal is to deliver a high-performance, biocompatible solution that meets the urgent clinical demand for advanced bone repair, particularly in complex orthopedic and trauma cases where traditional implants fall short.
Engineered Cartilage Repair
OssiGel is a cell-free biomaterial derived from engineered human cartilage. Our technology harnesses the natural biochemical signals of cartilage to stimulate the body's own regenerative processes, enabling the repair of complex bone defects without the need for living cells.
- Cell-free formulation for clinical safety
- Highly bioactive signaling molecules
- Biocompatible and biodegradable matrix
- Engineered for precise bone regeneration
Cartilage Engineering
We engineer human cartilage to serve as the biological foundation for OssiGel, ensuring high fidelity and biocompatibility for bone regeneration.
Our Research Goals
Biomaterial Design
We develop a cell-free gel matrix that mimics the natural extracellular environment, promoting optimal cell adhesion and tissue integration.
Regenerative Therapy
We aim to translate OssiGel into a clinical-grade therapy, offering a novel, cell-free solution for patients with complex bone repair needs.